TrivarX Limited
MDBIF
$0.0244
$0.02231,061.91%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 337.50K | 347.00K | -- | -- | 700.00 |
| Total Other Revenue | 30.30K | 31.20K | 286.60K | 286.00K | 6.20K |
| Total Revenue | 367.80K | 378.10K | 286.60K | 286.00K | 7.00K |
| Cost of Revenue | 5.80K | 6.00K | -- | -- | 1.00K |
| Gross Profit | 361.90K | 372.20K | 286.60K | 286.00K | 6.00K |
| SG&A Expenses | 176.60K | 181.60K | 142.00K | 141.70K | 113.60K |
| Depreciation & Amortization | 10.50K | 10.80K | 15.30K | 15.20K | 15.20K |
| Other Operating Expenses | 196.20K | 201.70K | 241.50K | 241.00K | 226.40K |
| Total Operating Expenses | 389.10K | 400.10K | 402.50K | 401.60K | 356.20K |
| Operating Income | -21.30K | -21.90K | -115.90K | -115.70K | -349.20K |
| Income Before Tax | -29.70K | -30.50K | -115.00K | -114.80K | -353.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -29.70K | -30.50K | -115.00K | -114.80K | -353.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.70K | -30.50K | -115.00K | -114.80K | -353.70K |
| EBIT | -21.30K | -21.90K | -115.90K | -115.70K | -349.20K |
| EBITDA | -10.80K | -11.10K | -100.60K | -100.40K | -334.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 454.63M | 454.63M | 358.40M | 358.40M | 306.22M |
| Average Diluted Shares Outstanding | 454.63M | 454.63M | 358.40M | 358.40M | 306.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |